ICON Public Limited Company (ICLR)
USD 139.77
(-2.63%)
USD 139.77
(-2.63%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 7.46 USD | 20.32% |
| 2022 | 6.20 USD | 171.93% |
| 2021 | 2.28 USD | -63.75% |
| 2020 | 6.29 USD | -9.37% |
| 2019 | 6.94 USD | 16.44% |
| 2018 | 5.96 USD | 18.25% |
| 2017 | 5.04 USD | 6.11% |
| 2016 | 4.75 USD | 16.42% |
| 2015 | 4.08 USD | 45.71% |
| 2014 | 2.80 USD | 65.68% |
| 2013 | 1.69 USD | 74.23% |
| 2012 | 0.97 USD | 155.26% |
| 2011 | 0.38 USD | -73.97% |
| 2010 | 1.46 USD | -9.32% |
| 2009 | 1.61 USD | 20.15% |
| 2008 | 1.34 USD | -31.28% |
| 2007 | 1.95 USD | 44.44% |
| 2006 | 1.35 USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 1.94 USD | 25.16% |
| 2003 | 1.55 USD | 27.05% |
| 2002 | 1.22 USD | 25.77% |
| 2001 | 0.97 USD | 76.36% |
| 2000 | 0.55 USD | -20.29% |
| 1999 | 0.69 USD | 146.43% |
| 1998 | 0.28 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 2.38 USD | 33.71% |
| 2024 Q2 | 1.78 USD | -21.59% |
| 2024 Q1 | 2.27 USD | -13.69% |
| 2023 Q1 | 1.43 USD | -0.69% |
| 2023 FY | - USD | 20.32% |
| 2023 Q4 | 2.63 USD | 32.16% |
| 2023 Q2 | 1.41 USD | -1.4% |
| 2023 Q3 | 1.99 USD | 41.13% |
| 2022 FY | - USD | 171.93% |
| 2022 Q1 | 1.37 USD | 45.74% |
| 2022 Q2 | 1.42 USD | 3.65% |
| 2022 Q3 | 1.96 USD | 38.03% |
| 2022 Q4 | 1.44 USD | -26.53% |
| 2021 FY | - USD | -63.75% |
| 2021 Q1 | 1.84 USD | -4.17% |
| 2021 Q4 | 0.94 USD | 180.34% |
| 2021 Q3 | -1.17 USD | -183.57% |
| 2021 Q2 | 1.40 USD | -23.91% |
| 2020 Q4 | 1.92 USD | 10.34% |
| 2020 Q3 | 1.74 USD | 91.21% |
| 2020 FY | - USD | -9.37% |
| 2020 Q2 | 0.91 USD | -44.17% |
| 2020 Q1 | 1.63 USD | -8.43% |
| 2019 Q2 | 1.70 USD | 3.66% |
| 2019 Q1 | 1.64 USD | 0.61% |
| 2019 Q3 | 1.73 USD | 1.76% |
| 2019 FY | - USD | 16.44% |
| 2019 Q4 | 1.78 USD | 2.89% |
| 2018 Q2 | 1.33 USD | -8.28% |
| 2018 FY | - USD | 18.25% |
| 2018 Q3 | 1.55 USD | 16.54% |
| 2018 Q4 | 1.63 USD | 5.16% |
| 2018 Q1 | 1.45 USD | 10.69% |
| 2017 Q3 | 1.37 USD | 14.17% |
| 2017 Q2 | 1.20 USD | -8.4% |
| 2017 Q1 | 1.31 USD | -2.96% |
| 2017 FY | - USD | 6.11% |
| 2017 Q4 | 1.31 USD | -4.38% |
| 2016 Q4 | 1.35 USD | 17.39% |
| 2016 Q3 | 1.15 USD | 4.55% |
| 2016 Q1 | 1.14 USD | 0.0% |
| 2016 FY | - USD | 16.42% |
| 2016 Q2 | 1.10 USD | -3.51% |
| 2015 Q1 | 0.93 USD | 25.68% |
| 2015 Q3 | 1.05 USD | 8.25% |
| 2015 FY | - USD | 45.71% |
| 2015 Q4 | 1.14 USD | 8.57% |
| 2015 Q2 | 0.97 USD | 4.3% |
| 2014 Q1 | 0.59 USD | 9.26% |
| 2014 FY | - USD | 65.68% |
| 2014 Q4 | 0.74 USD | -8.64% |
| 2014 Q2 | 0.66 USD | 11.86% |
| 2014 Q3 | 0.81 USD | 22.73% |
| 2013 Q4 | 0.54 USD | 17.39% |
| 2013 Q3 | 0.46 USD | 24.32% |
| 2013 Q2 | 0.37 USD | 15.63% |
| 2013 FY | - USD | 74.23% |
| 2013 Q1 | 0.32 USD | -5.88% |
| 2012 Q1 | 0.15 USD | 114.29% |
| 2012 Q2 | 0.13 USD | -13.33% |
| 2012 Q3 | 0.30 USD | 130.77% |
| 2012 Q4 | 0.34 USD | 13.33% |
| 2012 FY | - USD | 155.26% |
| 2011 Q2 | 0.22 USD | 57.14% |
| 2011 Q4 | 0.07 USD | 259.09% |
| 2011 Q3 | -0.04 USD | -120.0% |
| 2011 FY | - USD | -73.97% |
| 2011 Q1 | 0.14 USD | -61.11% |
| 2010 Q3 | 0.33 USD | -13.16% |
| 2010 Q2 | 0.38 USD | 0.0% |
| 2010 Q1 | 0.38 USD | -25.49% |
| 2010 FY | - USD | -9.32% |
| 2010 Q4 | 0.36 USD | 9.09% |
| 2009 Q4 | 0.51 USD | 24.39% |
| 2009 Q1 | 0.36 USD | 2.86% |
| 2009 FY | - USD | 20.15% |
| 2009 Q3 | 0.41 USD | 5.13% |
| 2009 Q2 | 0.39 USD | 8.33% |
| 2008 Q1 | 0.58 USD | 114.81% |
| 2008 FY | - USD | -31.28% |
| 2008 Q4 | 0.35 USD | -5.41% |
| 2008 Q3 | 0.37 USD | 15.63% |
| 2008 Q2 | 0.32 USD | -44.83% |
| 2007 Q3 | 0.50 USD | 8.7% |
| 2007 FY | - USD | 44.44% |
| 2007 Q1 | 0.43 USD | 126.32% |
| 2007 Q4 | 0.27 USD | -46.0% |
| 2007 Q2 | 0.46 USD | 6.98% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | 0.18 USD | -45.45% |
| 2006 Q4 | 0.19 USD | 5.56% |
| 2006 Q1 | 0.27 USD | 8.0% |
| 2006 Q2 | 0.33 USD | 22.22% |
| 2005 Q4 | 0.25 USD | 8.7% |
| 2005 FY | - USD | -100.0% |
| 2005 Q1 | -0.20 USD | -195.24% |
| 2005 Q2 | 0.21 USD | 205.0% |
| 2005 Q3 | 0.23 USD | 9.52% |
| 2004 FY | - USD | 25.16% |
| 2004 Q2 | 0.13 USD | -48.0% |
| 2004 Q3 | 0.13 USD | 0.0% |
| 2004 Q4 | 0.21 USD | 61.54% |
| 2004 Q1 | 0.25 USD | 8.7% |
| 2003 Q1 | 0.20 USD | 5.26% |
| 2003 FY | - USD | 27.05% |
| 2003 Q4 | 0.23 USD | 0.0% |
| 2003 Q3 | 0.23 USD | 109.09% |
| 2003 Q2 | 0.11 USD | -45.0% |
| 2002 Q4 | 0.19 USD | 11.76% |
| 2002 FY | - USD | 25.77% |
| 2002 Q2 | 0.08 USD | -51.56% |
| 2002 Q1 | 0.16 USD | 6.67% |
| 2002 Q3 | 0.17 USD | 119.35% |
| 2001 Q3 | 0.14 USD | 117.39% |
| 2001 Q1 | 0.13 USD | 8.33% |
| 2001 Q4 | 0.15 USD | 7.14% |
| 2001 Q2 | 0.06 USD | -50.46% |
| 2001 FY | - USD | 76.36% |
| 2000 Q3 | 0.11 USD | 0.0% |
| 2000 Q4 | 0.12 USD | 9.09% |
| 2000 Q2 | 0.11 USD | 21900.0% |
| 2000 Q1 | 0.00 USD | -98.89% |
| 2000 FY | - USD | -20.29% |
| 1999 Q4 | 0.04 USD | -43.75% |
| 1999 FY | - USD | 146.43% |
| 1999 Q2 | 0.08 USD | -27.27% |
| 1999 Q1 | 0.11 USD | 15.79% |
| 1999 Q3 | 0.08 USD | 0.0% |
| 1998 Q4 | 0.10 USD | 5.56% |
| 1998 Q2 | 0.09 USD | 33.38% |
| 1998 Q1 | 0.06 USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q3 | 0.09 USD | 3.81% |
| 1997 Q4 | 0.06 USD | 0.0% |
| 1997 Q3 | 0.06 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | 687.402% |
| Applied DNA Sciences, Inc. | -15.21 USD | 149.047% |
| Aspira Women's Health Inc. | -1.81 USD | 512.155% |
| Biodesix, Inc. | -0.64 USD | 1265.625% |
| BioNexus Gene Lab Corp. | -0.17 USD | 4488.235% |
| bioAffinity Technologies, Inc. | -0.91 USD | 919.78% |
| bioAffinity Technologies, Inc. | -0.91 USD | 919.78% |
| Bionano Genomics, Inc. | -6.81 USD | 209.545% |
| CareDx, Inc | -3.54 USD | 310.734% |
| Check-Cap Ltd. | -3.00 USD | 348.667% |
| Castle Biosciences, Inc. | -2.14 USD | 448.598% |
| DarioHealth Corp. | -1.93 USD | 486.528% |
| Exact Sciences Corporation | -1.13 USD | 760.177% |
| Fulgent Genetics, Inc. | -5.63 USD | 232.504% |
| Guardant Health, Inc. | -4.28 USD | 274.299% |
| IDEXX Laboratories, Inc. | 10.17 USD | 26.647% |
| Illumina, Inc. | -7.35 USD | 201.497% |
| Intelligent Bio Solutions Inc. | -6.38 USD | 216.928% |
| iSpecimen Inc. | -1.23 USD | 706.504% |
| Standard BioTools Inc. | -0.94 USD | 893.617% |
| MDxHealth SA | -1.66 USD | 549.398% |
| 23andMe Holding Co. | -1.40 USD | 632.857% |
| Medpace Holdings, Inc. | 9.20 USD | 18.913% |
| Myriad Genetics, Inc. | -1.39 USD | 636.691% |
| Mainz Biomed B.V. | -1.62 USD | 560.494% |
| ENDRA Life Sciences Inc. | -1.11 USD | 772.072% |
| NeoGenomics, Inc. | -0.70 USD | 1165.714% |
| Neogen Corporation | -0.04 USD | 17249.425% |
| Inotiv, Inc. | -4.10 USD | 281.951% |
| Natera, Inc. | -3.78 USD | 297.354% |
| OpGen, Inc. | -41.47 USD | 117.989% |
| OPKO Health, Inc. | -0.25 USD | 3084.0% |
| Psychemedics Corporation | -0.72 USD | 1136.111% |
| Prenetics Global Limited | -5.58 USD | 233.692% |
| Prenetics Global Limited | -5.58 USD | 233.692% |
| Precipio, Inc. | -4.51 USD | 265.41% |
| Personalis, Inc. | -2.25 USD | 431.556% |
| RadNet, Inc. | 0.05 USD | -15474.113% |
| Sera Prognostics, Inc. | -1.16 USD | 743.103% |
| Sotera Health Company | 0.18 USD | -4044.444% |
| Neuronetics, Inc. | -1.05 USD | 810.476% |
| Star Equity Holdings, Inc. | 7.42 USD | -0.539% |
| Star Equity Holdings, Inc. | 7.42 USD | -0.539% |
| Trinity Biotech plc | -3.14 USD | 337.58% |
| T2 Biosystems, Inc. | -19.19 USD | 138.874% |
| Twist Bioscience Corporation | -3.60 USD | 307.222% |
| Exagen Inc. | -1.34 USD | 656.716% |